Clinical trial
Combination Methotrexate and Infliximab
NCT00432432 · Chinese University of Hong Kong, Other · Completed
Key facts
| NCT number | NCT00432432 |
|---|---|
| Title | Combination Methotrexate and Infliximab |
| Official title | The Efficacy of Combination Methotrexate and Infliximab in Patients With Ankylosing Spondylitis:A Clinical and Magnetic Resonance Imaging Correlation |
| Lead sponsor | Chinese University of Hong Kong, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Ankylosing Spondylitis |
| Intervention type | Drug |
| Interventions | Infliximab and MTX |
| Enrollment | 38 |
| Start date | Feb 1, 2005 |
| Primary completion | Aug 1, 2006 |
| Completion | Oct 1, 2006 |
| First posted | Feb 7, 2007 |
| Last update posted | Feb 13, 2012 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: